Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of young patients with HNF1A mutations (HNF1A-MODY).

Diabetic medicine : a journal of the British Diabetic Association - 1 Apr 2015

Raile K, Schober E, Konrad K, Thon A, Grulich-Henn J, Meissner T, Wölfle J, Scheuing N, Holl R W

Abstract excerpt

AIM: Children and adolescents with a molecular diagnosis of HNF1A-MODY should be treated with oral sulfonylurea according to current International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. METHODS: We surveyed the German-Austrian DPV database of 50 043 people and included 114 patients with a confirmed molecular-genetic diagnosis of HNF1A mutation and diabetes onset at below age 18 years....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Benzamides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Drug Therapy, Combination

Share to Hepatocyte Nuclear Factor 1-alpha

Share to Hypoglycemia

Share to Hypoglycemic Agents

Share to Sulfonylurea Compounds

Source

Identifiers

PMID: 25483937
DOI: 10.1111/dme.12662

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of young patients with HNF1A mutations (HNF1A-MODY).PMID 25483937Read ↗

Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database.Semantic proximity Read ↗

Maturity onset diabetes of the young due to HNF1A variants in Croatia.Semantic proximity Read ↗

Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.Semantic proximity Read ↗

Case Report: Beyond type 1 diabetes: a case of delayed MODY1 diagnosis and successful transition to sulfonylurea therapySemantic proximity Read ↗

MODY in Ukraine: genes, clinical phenotypes and treatment.Semantic proximity Read ↗

Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV DatabaseSemantic proximity Read ↗

Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes.Semantic proximity Read ↗

Clinical and genetic characterization and long-term evaluation of individuals with maturity-onset diabetes of the young (MODY): The journey towards appropriate treatment.Semantic proximity Read ↗

Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes.Semantic proximity Read ↗

A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metforminSemantic proximity Read ↗

[Monogenic form of diabetes mellitus due to HNF4α mutation (MODY-1) - the first case in Hungary].Semantic proximity Read ↗

Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.